| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Institut für Tumorbiologie-Krebsforschung, Universität Wien, Borschkegasse 8a, 1090 Vienna, Austria [B. K-G., W. H., R. S-H.], and Unité de Biochimie Toxicologique et Cancerologique, Université Catholique de Louvain, UCL 7369, 1200 Brussels, Belgium [H. T.]
We investigated the mechanism of the hepatocarcinogenic action of nafenopin (NAF), a nongenotoxic peroxisome proliferator. Groups of male rats aged 13 wk (designated "young") or 57 wk (designated "old") were fed NAF for 13 mo; additional groups received a basal diet or a phenobarbital (PB)-containing diet as positive control.
The following results were obtained. (a) NAF produced numerous hepatocellular adenomas and carcinomas in old animals but very few in young animals. A similar result, although less pronounced, was seen with PB. Adenomas of PB-treated groups mostly consisted of eosinophilic and glycogen-storing cells. However, adenomas and carcinomas of NAF-treated livers were composed of weakly basophilic cells. (b) Phenotypically altered foci, evaluated in hematoxylin:eosin-stained sections, appeared spontaneously in untreated livers. The majority of these foci was either of the eosinophilic-clear cell or the tigroid cell type. In addition, we identified foci which are characterized by weak, diffuse cytoplasmatic basophilia. Their phenotype was similar to that of adenomas and carcinomas in NAF-treated rats. The number and size of eosinophilic-clear cell and of tigroid cell foci increased considerably with the age of the animals. At the end of the experiment, approximately 2.4% of liver tissue was occupied by focal cells. NAF, but not PB, treatment led to a selective increase in number and size of weakly basophilic foci. This subtype has previously been described as a likely precursor lesion for liver tumors induced by an aflatoxin B1-NAF initiation-promotion regimen (B. Kraupp-Grasl et al., Cancer Res., 50: 37013708, 1990).
These findings suggest that the peroxisome proliferator NAF leads to tumor development in aging rat liver by promotion of spontaneously occurring preneoplastic lesions. The type of lesion appears to be different from that promotable by PB.
1 To whom requests for reprints should be addressed.
Received 5/24/90. Accepted 10/29/90.
This article has been cited by other articles:
![]() |
C. Michel, C. Desdouets, M. Slaoui, K. R. Isaacs, R. A. Roberts, and E. Boitier Diethylnitrosamine Initiation Does Not Alter Clofibric Acid Induced Hepatocarcinogenesis in the Rat Toxicol. Sci., September 1, 2007; 99(1): 58 - 69. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Bursch, M. Chabicovsky, U. Wastl, B. Grasl-Kraupp, K. Bukowska, H. Taper, and R. Schulte-Hermann Apoptosis in Stages of Mouse Hepatocarcinogenesis: Failure to Counterbalance Cell Proliferation and to Account for Strain Differences in Tumor Susceptibility Toxicol. Sci., May 1, 2005; 85(1): 515 - 529. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Elrick, J. A. Kramer, C. L. Alden, E. A. G. Blomme, R. T. Bunch, M. A. Cabonce, S. W. Curtiss, L. D. Kier, K. L. Kolaja, C. P. Rodi, et al. Differential Display in Rat Livers Treated for 13 Weeks with Phenobarbital Implicates a Role for Metabolic and Oxidative Stress in Nongenotoxic Carcinogenicity Toxicol Pathol, January 1, 2005; 33(1): 118 - 126. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Rusyn, S. Yamashina, B. H. Segal, R. Schoonhoven, S. M. Holland, R. C. Cattley, J. A. Swenberg, and R. G. Thurman Oxidants from Nicotinamide Adenine Dinucleotide Phosphate Oxidase Are Involved in Triggering Cell Proliferation in the Liver Due to Peroxisome Proliferators Cancer Res., September 1, 2000; 60(17): 4798 - 4803. [Abstract] [Full Text] |
||||
![]() |
I. G. Shabalina, T. Panaretakis, A. Bergstrand, and J. W. Depierre Effects of the rodent peroxisome proliferator and hepatocarcinogen, perfluorooctanoic acid, on apoptosis in human hepatoma HepG2 cells Carcinogenesis, December 1, 1999; 20(12): 2237 - 2246. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Rose, R. C. Cattley, C. Dunn, V. Wong, X. Li, and R. G. Thurman Dietary glycine prevents the development of liver tumors caused by the peroxisome proliferator WY-14,643 Carcinogenesis, November 1, 1999; 20(11): 2075 - 2081. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Rokos and B. J. Ledwith Peroxisome Proliferators Activate Extracellular Signal-regulated Kinases in Immortalized Mouse Liver Cells J. Biol. Chem., May 16, 1997; 272(20): 13452 - 13457. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |